XML 35 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Balance Sheet Account Detail (Tables)
9 Months Ended
Sep. 30, 2014
Balance Sheet Related Disclosures [Abstract]  
Property, Plant and Equipment
Property and equipment consisted of the following:
 
September 30,
2014
 
December 31,
2013
Production equipment, molds, and office furniture
$
11,540

 
$
8,033

Computer hardware and software
5,061

 
3,290

Leasehold improvements
15,093

 
3,058

Construction in progress (software and related implementation, production equipment, and leasehold improvements)
2,548

 
2,594

Property and equipment, at cost
$
34,242

 
$
16,975

Accumulated depreciation
(11,179
)
 
(9,637
)
Property and equipment, net
$
23,063

 
$
7,338

Schedule of Inventory, Current
Inventories consisted of the following:
 
September 30,
2014
 
December 31,
2013
Raw materials
$
5,572

 
$
3,793

Work-in-process
6,589

 
4,539

Finished goods
15,585

 
11,226

Inventories
$
27,746

 
$
19,558

Schedule of Intangible Assets and Goodwill
The following table presents goodwill, indefinite lived intangible assets, finite lived intangible assets, and related accumulated amortization:
 

September 30,
2014

December 31,
2013
Goodwill (1)
$
28,944


$
29,103







Intangible assets:





Indefinite lived intangibles





Trademarks and trade names
$
2,708


$
2,708







Finite lived intangibles





Developed technology (2)
$
40,100


$
40,100

Accumulated amortization
(231
)

(48
)
Developed technology, net
$
39,869


$
40,052







Patent
$
100


$
100

Accumulated amortization
(100
)

(95
)
Patent, net
$


$
5







License
$
100


$
100

Accumulated amortization
(63
)

(41
)
License, net
$
37


$
59







Customer relationships (1)
$
501


$
544

Accumulated amortization
(376
)

(272
)
Customer relationships, net
$
125


$
272







Intangible assets (excluding goodwill), net
$
42,739


$
43,096

(1) Difference in the value between these dates is solely due to a foreign currency translation adjustment.
(2) Was reclassified in the first quarter of 2013 from in-process research and development to finite lived intangibles, which coincided with the European commercial launch of the product (Nellix EVAS System) associated with this intangible asset. A significant portion of this intangible asset will not begin amortization until the U.S. launch of this product, currently scheduled for 2016.
Schedule of Expected Amortization Expense
Estimated amortization expense for the five succeeding years and thereafter (which includes amortization of intangible assets which commenced in February 2013 with the commercial launch of the Nellix System in Europe) is as follows:

Amortization Expense
Remainder of 2014
$
110

2015
567

2016
946

2017
2,206

2018
3,682

2019
4,735

2020 & Thereafter
27,785

Total
$
40,031


Marketable Securities
Investments in held-to-maturity marketable securities consist of the following at September 30, 2014 and December 31, 2014:


September 30, 2014

Amortized
Cost

Gross
Unrealized
Gain
 
Gross
Unrealized
Loss
 
Fair Value












Asset backed securities
$
5,181


$
1


$


$
5,182

Corporate bonds
20,425


2


(11
)

20,416

Commercial paper
48,174


6


(2
)

48,178

Total
$
73,780


$
9


$
(13
)

$
73,776


















December 31, 2013

Amortized
Cost

Gross
Unrealized
Gain
 
Gross
Unrealized
Loss
 
Fair Value












Asset backed securities
$
1,405


$


$


$
1,405

Commercial paper
29,908


3


(3
)

29,908

Total
$
31,313


$
3


$
(3
)

$
31,313

Fair Value Measurements, Recurring and Nonrecurring
The following fair value hierarchy table presents information about each major category of the Company’s assets and liabilities measured at fair value on a recurring basis as of September 30, 2014 and December 31, 2013:

 Fair value measurement at reporting date using:
 
Quoted prices in
active markets for
identical assets
(Level 1)

Significant other
observable
inputs
(Level 2)

Significant
unobservable
inputs
(Level 3)

Total
At September 30, 2014











Cash and cash equivalents
$
27,537


$


$


$
27,537

Contingently issuable common stock




14,300


14,300

At December 31, 2013











Cash and cash equivalents
$
95,152


$


$


$
95,152

Contingently issuable common stock
$


$


60,900


60,900